🇺🇸 AMGN — Amgen Inc.

Healthcare Compra
← Volver

Precio actual

437,23 USD

Máx. histórico

447,03

10 días

Caída desde máximo

-2,19%

Rango 52 semanas

269,77 – 447,03

Variación hoy

-1,55%

Cierre anterior

444,12

Rango de hoy

435,01 – 441,66

Volumen hoy

1.615.172

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
27,17 (puede no estar actualizado)
Dividend yield
2,27% (puede no estar actualizado)
Precio objetivo analistas
389,69 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 2 días
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,27%
Fecha de pago Importe por participación
16/11/2022 1,9400 USD
17/08/2022 1,9400 USD
16/05/2022 1,9400 USD
14/02/2022 1,9400 USD
15/11/2021 1,7600 USD
16/08/2021 1,7600 USD
14/05/2021 1,7600 USD
11/02/2021 1,7600 USD
13/11/2020 1,6000 USD
14/08/2020 1,6000 USD
15/05/2020 1,6000 USD
13/02/2020 1,6000 USD
14/11/2019 1,4500 USD
14/08/2019 1,4500 USD
16/05/2019 1,4500 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
09/08/2017 173,10 174,18 172,65 173,55 -0,08% 0,88% 1.972.200
08/08/2017 173,96 174,90 172,98 173,69 -0,51% 1,10% 2.325.200
07/08/2017 173,87 174,65 173,26 174,58 +0,42% 0,80% 1.193.800
04/08/2017 174,27 174,82 172,90 173,85 -0,19% 1,10% 1.915.600
03/08/2017 173,52 174,71 173,26 174,18 -0,16% 0,84% 1.725.900
02/08/2017 173,57 174,59 173,21 174,46 +0,19% 0,80% 2.209.200
01/08/2017 174,81 175,11 173,66 174,13 -0,22% 0,83% 2.069.600
31/07/2017 174,51 176,79 174,25 174,51 -0,02% 1,46% 2.424.800
28/07/2017 171,98 175,06 171,71 174,54 +1,39% 1,95% 2.463.500
27/07/2017 175,00 175,48 170,53 172,15 -2,13% 2,83% 5.523.200
26/07/2017 176,01 178,86 175,20 175,89 -2,76% 2,08% 5.446.100
25/07/2017 182,05 182,60 180,34 180,89 -0,09% 1,24% 3.343.200
24/07/2017 180,19 181,46 178,66 181,06 +0,47% 1,55% 2.503.100
21/07/2017 179,26 180,55 179,16 180,21 +0,50% 0,78% 2.674.700
20/07/2017 179,05 180,73 178,88 179,32 +0,08% 1,03% 3.039.300
19/07/2017 178,10 179,20 176,52 179,18 +0,96% 1,50% 2.440.700
18/07/2017 176,66 177,63 176,14 177,48 +0,05% 0,84% 1.820.100
17/07/2017 176,84 178,90 176,68 177,40 +0,15% 1,26% 2.692.400
14/07/2017 175,43 177,68 174,41 177,13 +1,19% 1,86% 2.720.600
13/07/2017 173,28 176,20 173,09 175,04 +1,02% 1,79% 2.999.900
12/07/2017 173,71 174,24 172,67 173,27 -0,03% 0,90% 1.976.900
11/07/2017 174,18 174,44 172,07 173,32 +0,65% 1,36% 2.198.000
10/07/2017 171,59 172,55 171,00 172,20 +0,45% 0,90% 2.070.600
07/07/2017 171,64 172,03 170,59 171,43 -0,17% 0,84% 2.612.900
06/07/2017 173,10 173,61 171,31 171,72 -1,46% 1,33% 2.566.400
05/07/2017 172,67 174,38 171,92 174,26 +0,84% 1,42% 2.830.000
03/07/2017 172,63 174,33 172,63 172,80 +0,33% 0,98% 1.395.100
30/06/2017 173,61 174,25 172,01 172,23 -0,21% 1,29% 2.695.500
29/06/2017 174,49 174,72 171,02 172,59 -0,85% 2,12% 2.491.800
28/06/2017 171,42 174,54 170,83 174,07 +1,88% 2,16% 2.890.500